These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23253143)

  • 1. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting.
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2012 Dec; 11():424. PubMed ID: 23253143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting.
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2013 Jun; 12():213. PubMed ID: 23787092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting.
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2013 Dec; 12():456. PubMed ID: 24359206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of sixth biannual meeting (September 2014).
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2015 Mar; 14():107. PubMed ID: 25881119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of fifth biannual meeting (March 2014).
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2014 Jul; 13():253. PubMed ID: 24992998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of seventh biannual meeting (March 2015).
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2015 Aug; 14():295. PubMed ID: 26242747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations.
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2012 May; 11():137. PubMed ID: 22545931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015).
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2016 Feb; 15():117. PubMed ID: 26911803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania.
    Marchant T; Nathan R; Jones C; Mponda H; Bruce J; Sedekia Y; Schellenberg J; Mshinda H; Hanson K
    Malar J; 2008 Dec; 7():260. PubMed ID: 19094198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.
    Crawley J; Hill J; Yartey J; Robalo M; Serufilira A; Ba-Nguz A; Roman E; Palmer A; Asamoa K; Steketee R
    Lancet Infect Dis; 2007 Feb; 7(2):145-55. PubMed ID: 17251085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bigger babies for women given extra prophylaxis against malaria.
    BMJ; 2013 Feb; 346():f907. PubMed ID: 23407738
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
    Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
    Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing the policy for intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy in Malawi.
    Mwendera CA; de Jager C; Longwe H; Phiri K; Hongoro C; Mutero CM
    Malar J; 2017 Feb; 16(1):84. PubMed ID: 28219435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing uptake of intermittent preventive treatment of malaria in pregnancy using sulphadoxine pyrimethamine in Sunyani Municipality, Ghana.
    Ibrahim H; Maya ET; Issah K; Apanga PA; Bachan EG; Noora CL
    Pan Afr Med J; 2017; 28():122. PubMed ID: 29515740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the knowledge of intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine in Ivory Coast].
    Yavo JC; Amari ASG; Assi SB; Assemian A; Kouamé R; Balayssac E; Kamagaté M
    Therapie; 2019 Sep; 74(4):487-494. PubMed ID: 30904318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy.
    Deloron P; Bertin G; Briand V; Massougbodji A; Cot M
    Emerg Infect Dis; 2010 Nov; 16(11):1666-70. PubMed ID: 21029522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent preventive treatment against malaria: an update.
    Gosling RD; Cairns ME; Chico RM; Chandramohan D
    Expert Rev Anti Infect Ther; 2010 May; 8(5):589-606. PubMed ID: 20455687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.